James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries.
Sarah spent most of her life in a hospital bed until Celltex used her own stem cells to heal her body. She’s doing better than anyone ever imagined, and now she’s helping others who are desperate for medical help.
Former U.S. Secretary of Energy and former Governor of Texas, Rick Perry, was on Fox News TV discussing Celltex’s COVID-19 ongoing clinical trials and the ingenuity that will deliver a victory over this virus.
Dr. Derek W. Guillory, Founder and Medical Director of Root Causes Medicine in San Antonio and Principal Investigator for Celltex’s upcoming clinical trial was recently brought on as a guest of the Erick Erickson Show on WSB Radio.
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. On March 21st, 2020, Celltex submitted an emergency expanded access clinical study to the United States Food and Drug Administration (FDA) that would allow patients with COVID-19 to receive infusions of autologous Adipose-tissue derived Mesenchymal Stem Cells (AdMSCs) in the US.
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China.
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. ChinaXiv has performed a recent study that has proven significant improvement of a critically ill COVID-19 patient that was treated with the transfer of human umbilical cord mesenchymal stem cells.
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. Celltex is continuing to monitor and participate in this promising research.